Expression of DBC1 is associated with poor prognosis in hepatitis virus-related hepatocellular carcinoma.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Pathology, Research and Practice

• Publication date

  2016-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.prp.2016.04.001PMID 27083241
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DBC1 is over-expressed and associated with poor prognosis in colorectal cancer

  2014cited by this paper
• CHD1L Is a Marker for Poor Prognosis of Hepatocellular Carcinoma after Surgical Resection

  2013cited by this paper
• Hepatocellular carcinoma

  2012cited by this paper
• The overexpression of DBC1 in esophageal squamous cell carcinoma correlates with poor prognosis.

  2012cited by this paper
• DBC1 does not function as a negative regulator of SIRT1 in liver cancer.

  2012cited by this paper
• Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma.

  2011cited by this paper
• DBC-1 mediates endocrine resistant breast cancer cell survival

  2010cited by this paper
• Deleted in breast cancer 1 (DBC1) is a dynamically regulated protein.

  2010cited by this paper
• Deleted in breast cancer-1 regulates SIRT1 activity and contributes to high-fat diet-induced liver steatosis in mice.

  2010cited by this paper
• Expression of DBC1 and SIRT1 Is Associated with Poor Prognosis of Gastric Carcinoma

  2009cited by this paper
• Identification and Characterization of a Novel Nuclear Protein Complex Involved in Nuclear Hormone Receptor-mediated Gene Regulation*

  2009cited by this paper
• DBC1 is a negative regulator of SIRT1

  2008cited by this paper
• Resection and Liver Transplantation for Hepatocellular Carcinoma

  2005cited by this paper
• Focus on hepatocellular carcinoma.

  2004cited by this paper
• AJCC Cancer Staging Manual

  2002cited by this paper
• DBC2, a candidate for a tumor suppressor gene involved in breast cancer

  2002cited by this paper
• Genetics of hepatocellular carcinoma.

  2000cited by this paper
• Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification

  1999cited by this paper
• Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma

  1997cited by this paper
• Terminology of nodular hepatocellular lesions

  1995cited by this paper
• Terminology of nodular hepatocellular lesions.

  1995cited by this paper
• A genetic model for colorectal tumorigenesis.

  1990cited by this paper

• Prognostic and clinicopathological value of dbc1 expression in human cancers: a systematic review and meta-analysis

  2025cites this paper
• Multifaceted roles of CCAR family proteins in the DNA damage response and cancer

  2024cites this paper
• Mechanistic insights into the dual role of CCAR2/DBC1 in cancer

  2023cites this paper
• Interaction of DBC1 with polyoma small T antigen promotes its degradation and negatively regulates tumorigenesis

  2021cites this paper
• Advances on the role of the deleted in breast cancer (DBC1) in cancer and autoimmune diseases

  2020cites this paper
• Rab25 Acts as a Promising Novel Bio-Marker in the Prognosis of Patients with Hepatocellular Carcinoma

  2020cites this paper
• A CREB 1 / miR-433 reciprocal feedback loop modulates proliferation and metastasis in colorectal cancer

  2019cites this paper
• Deleted in breast cancer 1 as a potential prognostic biomarker in human cancers: a pooled analysis of 2,254 patients

  2019influential citation
• Deleted in Breast Cancer 1 as a Novel Prognostic Biomarker for Digestive System Cancers: A Meta-Analysis

  2019influential citation
• A novel form of Deleted in breast cancer 1 (DBC1) lacking the N-terminal domain does not bind SIRT1 and is dynamically regulated in vivo

  2019cites this paper
• A CREB1/miR-433 reciprocal feedback loop modulates proliferation and metastasis in colorectal cancer

  2018cites this paper
• ZNF326 promotes a malignant phenotype of breast cancer by interacting with DBC1

  2018cites this paper
• Cell cycle and apoptosis regulator 2 at the interface between DNA damage response and cell physiology.

  2018cites this paper
• Diagnostic value of strand‐specific miRNA‐101‐3p and miRNA‐101‐5p for hepatocellular carcinoma and a bioinformatic analysis of their possible mechanism of action

  2017cites this paper
• CCAR2 negatively regulates IL-8 production in cervical cancer cells

  2017cites this paper
• Overexpression of DBC1, correlated with poor prognosis, is a potential therapeutic target for hepatocellular carcinoma.

  2017cites this paper